Nevro® TLEAD1058-50B
Nevro® TLEAD1058-50B is a Class III device made by Nevro Corporation, approved under FDA PMA P130022 on 8 May 2015 and listed in FDA GUDID since 21 May 2015 (UDI-DI 00813426020367), active as of 22 Oct 2026.
Active
PMA
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number00813426020367 | Date21 May 2015 | StatusListed |
| United States | FDA PMAAPPR | NumberP130022 | Date8 May 2015 | StatusActive |
Official records
- AccessGUDID record 00813426020367
- FDA PMA database P130022
Across registries
- FDA PMA P130022 decided 8 May 2015 Active
- FDA GUDID UDI-DI 00813426020367 listed 21 May 2015 Listed
Timeline
- Approved FDA PMA P130022
- Listed FDA GUDID 00813426020367
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA PMA Active
Specification
- Trade name
- Nevro®
- Generic name
- Spinal cord/peripheral nerve implantable analgesic electrical stimulation system lead, wired connection
- Model / Ref / Catalog
- TLEAD1058-50B
- Primary DI / UDI-DI
- 00813426020367
- PMA number
- FDA product code
- LGW
- GMDN term
- Spinal cord/peripheral nerve implantable analgesic electrical stimulation system lead, wired connection
- Device class
- Class III
- GUDID distribution status
- In Commercial Distribution
- MRI safety
- MR Conditional